Clinical Trial Update: Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases [Phase 2]

View source ↗

Summary

A Phase 2 trial update comparing micafungin to intravenous itraconazole as empirical antifungal therapy in febrile neutropenia patients with hematologic disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia
• Hematologic Diseases

Drugs mentioned

• Itraconazole (Itraconazole)
• Micafungin (micafungin)

Snippet

Sponsor: Yonsei University | Conditions: Febrile Neutropenia, Hematological Diseases | Phase 2 | Status: COMPLETED